Emkay Global Financial Services has maintained hold rating on Dr Reddys Laboratories with a target price of Rs 1650 in its February 3, 2012 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!